64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression

Clinical trial NCT04605614 · WITHDRAWN

Trial details

NCT number: NCT04605614
Sponsor: City of Hope Medical Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

Start date: 2022-04-15
Primary completion: 2022-05-16
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.